44
Participants
Start Date
September 23, 2015
Primary Completion Date
June 15, 2021
Study Completion Date
June 15, 2021
Oraxol
"Paclitaxel:~5β,20-Epoxy-1,2α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13- ester with (2R,3S)-N-benzoyl-3-phenylisoserine~HM30181 methanesulfonate monohydrate:~N-(2-(2-(4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl)-4-oxo-4H-chromene-2-carboxamide Methanesulfonate monohydrate"
Tri-Service General Hospital, Taipei
Monash Medical Centre, Clayton
Taipei Medical University Shuang Ho Hospital, New Taipei City
Auckland City Hospital, Auckland
Dunedin Hospital, Dunedin
Wellington Regional Hospital, Wellington
Lotung Poh-Ai Hospital, Yilan
The Christie NHS Foundation Trust, Manchester
Lead Sponsor
Collaborators (1)
Zenith Technology Corporation Limited
INDUSTRY
PharmaEssentia
INDUSTRY
Athenex, Inc.
INDUSTRY